A winner has emerged in the ongoing battle of the bulge: Mounjaro. Overweight or obese adults are three times more likely to shed 15% of their body weight on Mounjaro than Ozempic, according to a ...

Weight-loss jab Mounjaro – dubbed the “King Kong” of similar medicines – helps people shed significantly more weight than rival Wegovy, new research suggests. Key research pitching the drugs against ...

Eli Lilly and Co. LLY has come out on top in a weight loss drug competition in a recent study. The study found that patients on Lilly’s Mounjaro lost more weight than those on Novo Nordisk’s NVO ...

Using Mounjaro for one year led to more weight loss than Ozempic did in a study of 18,386 patients, according to the results published July 8 in JAMA Internal Medicine. “This study represents the ...

Both medications are FDA-approved for people with Type 2 diabetes. As the popularity of drugs used for weight loss continues to explode, a new study is shedding light on which drug is most effective ...

In the first head-to-head study, researchers tracked people living with obesity who take Tirzepatide, also known as Mounjaro, and others who take Semaglutide, or Ozempic. Now that the drugs are more ...

Overweight and obese adults using popular diabetes medications to suppress their appetites are “significantly more likely” to shed pounds with Eli Lilly’s Mounjaro than with Novo Nordisk’s Ozempic, a ...

The kids are alright — on GLP-1s, that is. A new study found that the blockbuster treatment Mounjaro can dramatically lower blood sugar and body weight in children as young as 10 with Type 2 diabetes.

New research from the Technical University of Munich and Harvard Medical School reveals that popular GLP-1-based drugs, semaglutide (Ozempic) and tirzepatide (Mounjaro), not only promote weight loss ...

For Monday, May 12, WGN’s Dina Bair has the latest on new medical information, including: In the first head-to-head study, researchers tracked people living with obesity who take Tirzepatide, also ...